Physician profile
Wayne H Case
NPI 1215928916
$5,960.60
in general payments reported to CMS, 2019-2025
44 companies · $854 in 2025
The $854 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,106 · 2020: $557 · 2021: $965 · 2022: $795 · 2023: $1,065 · 2024: $618 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $837.56 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $783.02 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $454.45 | 2019-2025 | Qulipta, Ubrelvy, Synthroid |
| Glaxosmithkline, LLC. | $365.83 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $350.50 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $340.47 | 2019-2025 | Airsupra, Andexxa |
| Exact Sciences Corporation | $331.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Vanda Pharmaceuticals INC. | $318.14 | 2022-2023 | Hetlioz |
| Biohaven Pharmaceuticals, INC. | $244.17 | 2020-2021 | |
| Kvk-Tech, INC. | $200.95 | 2019-2021 | |
| Amarin Pharma, INC. | $149.47 | 2019-2021 | |
| Allergan, INC. | $146.94 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.58 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $137.17 | 2023-2024 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $129.84 | 2019-2023 | Austedo Xr |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.